L. L. Ross, “Impact of HIV subtype on response and resistance in antiretroviral-naïve adults comparing treatment with once daily versus twice daily ritonavir boosted fosamprenavir in combination with Abacavir/Lamivudine”, Drugs Ther Studies, vol. 2, no. 1, p. e1, Dec. 2011.